Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Public ClinicalTrials.gov record NCT03150914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to determine if early, long-term low dose sirolimus is effective for preventing progression to more advanced stages.
Study identification
- NCT ID
- NCT03150914
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2018 (Actual)
- Primary completion
- Jun 30, 2025 (Estimated)
- Completion
- Jun 30, 2025 (Estimated)
- Last update posted
- Dec 24, 2024
2018 – 2025
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305 | — |
| National Jewish Hospital | Denver | Colorado | 80206-2761 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Loyola University | Chicago | Illinois | 60153 | — |
| Brigham and Woman's Hospital | Boston | Massachusetts | 20892 | — |
| University of Cincinnati | Cincinnati | Ohio | 45174 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Swedish Health | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03150914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 24, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03150914 live on ClinicalTrials.gov.